“Multiple Sclerosis”
Event Navigation
Download a copy of this content.
HealthTrust presents…”Multiple Sclerosis”
Multiple sclerosis is a lesser known and complex disease state. There remains a gap in knowledge of the prevalence, etiology, phenotypes and treatment options of multiple sclerosis. Individualizing treatment regimens remains a particular challenge to encourage compliance while providing sufficient treatment to prevent disease progression for multiple sclerosis. Additionally, there is little data to directly compare and contrast disease modifying therapies. In this session, the presenter will examine multiple sclerosiss’ etiology, phenotypes, diagnosis mechanisms and treatment options. Medications discussed include disease-modifying therapy (DMT), a class of medications that reduces the frequency of relapses and progression of multiple sclerosis. Individual mechanisms, route of administration, dosing regimens, side effect profiles and indications for use will be discussed and reflect the most current treatment paradigm. The presenter will also briefly review additional supportive therapy.
Learning Objectives for Pharmacists and Nurses | At the end of the session, participants should be able to:
- Describe immune dysregulation as pathogenesis of MS
- Identify therapeutic goals and outcome measures for a patient started on MS therapy
- Compare & contrast disease-modifying agents in terms of efficacy, saftey, ease of administration, place in
therapy, and patient-specific considerations
Learning Objectives for Pharmacy Techs | At the end of the session, participants should be able to:
- Describe risk factors and symptoms of MS
- Identify routes of administration for disease modifying therapies for MS
Presenter:
Christopher Makosiej, PharmD | PGY-1 Pharmacy Resident | Saint Barnabas Medical Center | RWJBarnabas Health System
Target Audience: Pharmacists, Pharmacy Techs and Nurses
Continuing Education Information: 1.0 contact hour approved for Nurses, Pharmacists and Pharmacy Techs. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Numbers for this activity are 0863-9999-20-052-L01-P and 0863-9999-20-052-L01-T. The activity is approved for 1 hour (.1 CEUs) of continuing education credit for Nurses, Pharmacists and Pharmacy Techs who attend the webinar and complete the online evaluation.
California Board of Registered Nursing Approval. Pfiedler is a provider approved by the California Board of Registered Nursing, Provider Number CEP 14944 for 1.0 contact hour.
Note about CE credit: If you plan to obtain credit, stay until the end of the presentation to receive the verification code you will need to obtain your continuing education credit. A reminder that CE credit is individual. No group credit is available. Each person must register for this session and attend the entire webinar in order to receive an email after the event with instructions on how to apply for continuing education credit. Please do not share the code or forward the email you receive to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. Also, please note: If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.
Effective June 1, 2019: Belmont College of Pharmacy will no longer issue paper/electronic statements of credit for CE activities. ACPE (our accrediting body) policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor at www.nabp.net. A participant, sponsor, faculty member or other individual wanting to file a grievance with respect to any aspect of a program sponsored or co-sponsored by the Belmont COP may contact the Dean of Belmont University College of Pharmacy in writing at david.gregory@belmont.edu. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.
